Teva Pharmaceuticals President & CEO Richard Francis, discusses why Teva chose to make the change now and what will be different for investors as the shares move from ADRs to direct NYSE trading. He speaks with Romaine Bostick & Isabelle Lee on "The Close." (Source: Bloomberg)
Nous affichons publiquement l'idee principale. Creez un compte gratuit pour lire l'article complet, l'enregistrer, le commenter et le relier au contexte marches et OSINT.